Celltrion Healthcare Showcases Positive Data on Switching and Monotherapy With Remsima® SC in Patients With Inflammatory Bowel Disease at UEG Week Virtual 2021

View Full Size 

Download

• Full Size JPEG, 2526x822, 153.4 KB
• Small JPEG, 480x156, 24.8 KB
• Preview JPEG, 144x47, 5.3 KB
• Thumbnail JPEG, 120x39, 3.7 KB